Thursday, May 23, 2013 Last update: 6:35 PM
Company Tech News as it Breaks
Trade Events
Alexion Pharmaceuticals, Inc.
News articles for Alexion Pharmaceuticals, Inc.:
Thursday, May 23, 2013
- Alexion to Present at the Deutsche Bank 38th Annual dbAccess Health Care ConferenceAlexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the Deutsche Bank 38th Annual dbAccess Health Care ... read more
Wednesday, May 8, 2013
- Alexion to Present at the BofA Merrill Lynch 2013 Healthcare ConferenceAlexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the BofA Merrill Lynch 2013 Healthcare Conference in ... read more
Thursday, April 25, 2013
- Alexion Reports First Quarter 2013 ResultsAlexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results and a development pipeline update for the three months ended March 31, 2013. The Company reported net product sales ... read moreAlexion Broadens and Strengthens its Executive Leadership TeamAlexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that it is broadening and strengthening its executive leadership team in line with the Company’s expanding global mission to develop and ... read more
Thursday, March 14, 2013
- Alexion Joins the International Federation of Kidney Foundations in Celebrating World Kidney Day 2013Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced its support of World Kidney Day 2013, a global awareness campaign led by the International Society of Nephrology (ISN) and the ... read more
Tuesday, March 5, 2013
- Alexion to Present at the Barclays Global Healthcare ConferenceAlexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the Barclays Global Healthcare Conference in Miami at 10:45 ... read more
Thursday, February 28, 2013
- Alexion Joins Eurordis, NORD and Patient Organizations Worldwide in Celebrating Rare Disease Day 2013Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN), joins the European Organization for Rare Diseases (EURORDIS), the National Organization for Rare Disorders (NORD) and patient organizations worldwide in celebrating ... read more
Monday, February 25, 2013
- Alexion to Present at the Cowen and Company 33rd Annual Health Care ConferenceAlexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Cowen and Company 33rd Annual Health Care ... read more
Thursday, February 7, 2013
- Alexion Recommends Rejection of Mini-Tender Offer by TRC Capital CorporationAlexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation to purchase up to 1.5 million shares, or approximately 0.77%, of ... read more
Thursday, January 31, 2013
- Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2012 Results on Thursday, February 14, 2013Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the fourth quarter and year ended December 31, 2012 on Thursday, February ... read more
Wednesday, January 2, 2013
- Alexion to Present at the JP Morgan 31st Annual Healthcare ConferenceAlexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the JP Morgan 31st Annual Healthcare Conference in ... read more
Monday, December 10, 2012
- New Data Highlighting Long-Term Efficacy and Safety Outcomes of PNH Patients Treated with Soliris® Reported at ASH Annual MeetingAlexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced the presentation of new data demonstrating the long-term benefits of Soliris® (eculizumab) in patients with paroxysmal nocturnal hemoglobinuria ... read more